12-120473010-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001037494.2(DYNLL1):​c.-7+2906C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.26 in 152,048 control chromosomes in the GnomAD database, including 5,981 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5981 hom., cov: 31)

Consequence

DYNLL1
NM_001037494.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.494

Publications

10 publications found
Variant links:
Genes affected
SRSF9 (HGNC:10791): (serine and arginine rich splicing factor 9) The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two pseudogenes, one on chromosome 15 and the other on chromosome 21, have been found for this gene. [provided by RefSeq, Sep 2010]
DYNLL1 (HGNC:15476): (dynein light chain LC8-type 1) Cytoplasmic dyneins are large enzyme complexes with a molecular mass of about 1,200 kD. They contain two force-producing heads formed primarily from dynein heavy chains, and stalks linking the heads to a basal domain, which contains a varying number of accessory intermediate chains. The complex is involved in intracellular transport and motility. The protein described in this record is a light chain and exists as part of this complex but also physically interacts with and inhibits the activity of neuronal nitric oxide synthase. Binding of this protein destabilizes the neuronal nitric oxide synthase dimer, a conformation necessary for activity, and it may regulate numerous biologic processes through its effects on nitric oxide synthase activity. Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.481 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001037494.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DYNLL1
NM_001037494.2
c.-7+2906C>T
intron
N/ANP_001032583.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRSF9
ENST00000957767.1
c.-106+1626G>A
intron
N/AENSP00000627826.1
SRSF9
ENST00000957768.1
c.-106+560G>A
intron
N/AENSP00000627827.1
SRSF9
ENST00000706469.1
c.89+1626G>A
intron
N/AENSP00000516402.1

Frequencies

GnomAD3 genomes
AF:
0.260
AC:
39478
AN:
151930
Hom.:
5968
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.110
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.273
Gnomad ASJ
AF:
0.232
Gnomad EAS
AF:
0.496
Gnomad SAS
AF:
0.299
Gnomad FIN
AF:
0.334
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.318
Gnomad OTH
AF:
0.250
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.260
AC:
39502
AN:
152048
Hom.:
5981
Cov.:
31
AF XY:
0.264
AC XY:
19597
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.110
AC:
4559
AN:
41474
American (AMR)
AF:
0.274
AC:
4185
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.232
AC:
806
AN:
3468
East Asian (EAS)
AF:
0.497
AC:
2566
AN:
5166
South Asian (SAS)
AF:
0.300
AC:
1445
AN:
4810
European-Finnish (FIN)
AF:
0.334
AC:
3528
AN:
10568
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.318
AC:
21606
AN:
67968
Other (OTH)
AF:
0.246
AC:
520
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1451
2901
4352
5802
7253
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.288
Hom.:
8462
Bravo
AF:
0.249
Asia WGS
AF:
0.352
AC:
1227
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
10
DANN
Benign
0.68
PhyloP100
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10849753; hg19: chr12-120910813; API